AP -- Biotechnology company Amgen Inc. said Monday second-quarter profit jumped 40 percent on a tax benefit and lower costs following a restructuring program, despite a continued decline in anemia drug sales.
AP -- Biotechnology company Amgen Inc. said Monday second-quarter profit jumped 40 percent on a tax benefit and lower costs following a restructuring program, despite a continued decline in anemia drug sales.
